Evidence map›Paper›PMID 39776858›Full record

ReviewRegenerative biomaterials2025

Advancements in nanohydroxyapatite: synthesis, biomedical applications and composite developments.

Rui Zhao, Xiang Meng, Zixian Pan, Yongjia Li, Hui Qian, Xiangdong Zhu, Xiao Yang, Xingdong Zhang

Abstract readReview
In one paragraph

Review in Regenerative biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Multifunctional rGO/YRSC advances · 2026
    Article
  14. Three-dimensionally-printed biphasic PCL/Regenerative biomaterials · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui ZhaoSchool of Medicine, Department of Inspection, Jiangsu University, Zhenjiang 212013, China.
Xiang MengSchool of Medicine, Department of Inspection, Jiangsu University, Zhenjiang 212013, China.
Zixian PanSchool of Medicine, Department of Inspection, Jiangsu University, Zhenjiang 212013, China.
Yongjia LiSchool of Medicine, Department of Inspection, Jiangsu University, Zhenjiang 212013, China.
Hui QianSchool of Medicine, Department of Inspection, Jiangsu University, Zhenjiang 212013, China.
Xiangdong ZhuNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.ORCID https://orcid.org/0000-0002-3818-7419
Xiao YangNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.ORCID https://orcid.org/0000-0001-7248-8218
Xingdong ZhangNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanohydroxyapatite (nHA) is distinguished by its exceptional biocompatibility, bioactivity and biodegradability, qualities attributed to its similarity to the mineral component of human bone. This review discusses the synthesis techniques of nHA, highlighting how these methods shape its physicochemical attributes and, in turn, its utility in biomedical applications. The versatility of nHA is further enhanced by doping with biologically significant ions like magnesium or zinc, which can improve its bioactivity and confer therapeutic properties. Notably, nHA-based composites, incorporating metal, polymeric and bioceramic scaffolds, exhibit enhanced osteoconductivity and osteoinductivity. In orthopedic field, nHA and its composites serve effectively as bone graft substitutes, showing exceptional osteointegration and vascularization capabilities. In dentistry, these materials contribute to enamel remineralization, mitigate tooth sensitivity and are employed in surface modification of dental implants. For cancer therapy, nHA composites offer a promising strategy to inhibit tumor growth while sparing healthy tissues. Furthermore, nHA-based composites are emerging as sophisticated platforms with high surface ratio for the delivery of drugs and bioactive substances, gradually releasing therapeutic agents for progressive treatment benefits. Overall, this review delineates the synthesis, modifications and applications of nHA in various biomedical fields, shed light on the future advancements in biomaterials research.

Indexed as

bone regenerationcancer therapycomposite materialdentistrynanohydroxyapatite

Identifiers

PMID39776858
PMCPMC11703556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.